Literature DB >> 34203921

From Sampling to Sequencing: A Liquid Biopsy Pre-Analytic Workflow to Maximize Multi-Layer Genomic Information from a Single Tube.

Kendra K Maass1,2, Paulina S Schad1, Agnes M E Finster1, Pitithat Puranachot3,4, Fabian Rosing1,2, Tatjana Wedig1,2, Nathalie Schwarz1, Natalie Stumpf1, Stefan M Pfister1,2, Kristian W Pajtler1,2.   

Abstract

Liquid biopsies hold great promise for the management of cancer. Reliable liquid biopsy data depend on stable and reproducible pre-analytical protocols that comply with quality measures, irrespective of the sampling and processing site. We established a workflow for plasma preservation, followed by processing, cell-free nucleic acid isolation, quantification, and enrichment of potentially tumor-derived cell-free DNA and RNA. Employing the same input material for a direct comparison of different kits and protocols allowed us to formulate unbiased recommendations for sample collection, storage, and processing. The presented workflow integrates the stabilization in Norgen, PAX, or Streck tubes and subsequent parallel isolation of cell-free DNA and RNA with NucleoSnap and NucleoSpin. Qubit, Bioanalyzer, and TapeStation quantification and quality control steps were optimized for minimal sample use and high sensitivity and reproducibility. We show the efficiency of the proposed workflow by successful droplet digital PCR amplification of both cell-free DNA and RNA and by detection of tumor-specific alterations in low-coverage whole-genome sequencing and DNA methylation profiling of plasma-derived cell-free DNA. For the first time, we demonstrated successful parallel extraction of cell-free DNA and RNA from plasma samples. This workflow paves the road towards multi-layer genomic analysis from one single liquid biopsy sample.

Entities:  

Keywords:  CSF; blood preservation tubes; cancer; cell-free DNA; cell-free RNA; droplet digital PCR; liquid biopsy; low-coverage whole-genome sequencing; pre-analytics; size selection

Year:  2021        PMID: 34203921     DOI: 10.3390/cancers13123002

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  5 in total

Review 1.  Circulating tumor DNA profiling for childhood brain tumors: Technical challenges and evidence for utility.

Authors:  Anthony Pak-Yin Liu; Paul A Northcott; Giles W Robinson; Amar Gajjar
Journal:  Lab Invest       Date:  2021-12-21       Impact factor: 5.662

2.  Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers.

Authors:  Maartje Massen; Kim Lommen; Kim A D Wouters; Johan Vandersmissen; Wim van Criekinge; James G Herman; Veerle Melotte; Leo J Schouten; Manon van Engeland; Kim M Smits
Journal:  Clin Epigenetics       Date:  2022-04-27       Impact factor: 7.259

Review 3.  A clinician's handbook for using ctDNA throughout the patient journey.

Authors:  Samantha O Hasenleithner; Michael R Speicher
Journal:  Mol Cancer       Date:  2022-03-21       Impact factor: 27.401

4.  Low-coverage whole-genome sequencing of cerebrospinal-fluid-derived cell-free DNA in brain tumor patients.

Authors:  Anthony P Y Liu; Kyle S Smith; Rahul Kumar; Giles W Robinson; Paul A Northcott
Journal:  STAR Protoc       Date:  2022-04-12

5.  Liquid Biopsy, an Everchanging Balance between Clinical Utility and Emerging Technologies.

Authors:  Linda Cucciniello; Lorenzo Gerratana; Fabio Puglisi
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.